A Randomized, Single-blind, Controlled Clinical Study of Cardiomyopeptidin on Improving Ischemia-reperfusion Injury in Patients With Acute ST-segment Elevation Myocardial Infarction After Primary PCI
Clinical trial NCT06155110 · COMPLETED
Trial details
- NCT number
- NCT06155110
- Sponsor
- Chinese PLA General Hospital
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-01
- Primary completion
- 2025-03-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.